Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib + Decitabine in Accelerated/Blast Phase MPN
NCT02076191Phase 2Completed
- Sponsor
- John Mascarenhas
- Start
- Feb 2014
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ruxolitinib in Myeloproliferative Neoplasm (MPN), myeloproliferative neoplasm blast phase (BP-MPN), sponsored by John Mascarenhas. Started Feb 2014; status: completed.
02
Drugs
03
Conditions
Myeloproliferative Neoplasm (MPN)myeloproliferative neoplasm blast phase (BP-MPN)
Beyond the preview
Go deeper on NCT02076191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02076191.